Pharmacokinetics and metabolism of genaconazole, a potent antifungal drug, in men

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 1, 1996, Pages 92-96

  Lin, C ^a   Kim, H ^a   Radwanski, E ^a   Affrime, M ^a   Brannan, M ^a   Cayen, M N ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENACONAZOLE;

ADULT; ANTIFUNGAL ACTIVITY; ARTICLE; CLINICAL TRIAL; CONFORMATIONAL TRANSITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG CONFORMATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG POTENCY; DRUG TRANSFORMATION; HUMAN; HUMAN EXPERIMENT; MALE; MAXIMUM ALLOWABLE CONCENTRATION; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RACEMIC MIXTURE; RANDOMIZED CONTROLLED TRIAL;

EID: 0030032265     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.1.92     Document Type: Article

References (8)

1. Daneshmend, T. K., D. W. Warnock, A. Turner, and C. J. C. Roberts. 1981. Pharmacokinetics of Ketoconazole in normal subjects. J Antimicrob. Chemother. 8:299-304
2. Hardin, T. C., J. R. Graybill, R. Fetchick, R. Woestenborghs, and M. G. Rinalid. 1988. Pharmacokinetics of itraconazole following oral administration to normal volunteers Antimicrob. Agents Chemother. 32:1310-1313
3. Huang, Y. C., J. G. Colaizzi, R. H. Bierman, R. Woestenborghs, and J. Heykant. 1986. Pharmacokinetics and dose proportionality of ketoconazolc in normal volunteers. Antimicrob Agents Chemother. 30:206-210.
4. Lee, J. W., C. Lin, D. Loebenberg, M. Rubin, P. A. Pizzo, and T. J. Walsh. 1989. Pharmacokinetics and tissue penetration of SCH 39304 in granulocytopenic and nongranulocytopenic rabbits. Antimicrob. Agents Chemother. 33: 1932-1935.
5. Lin, C., H. Kim, A. Lapiguera, and S. Symchowicz. 1989. Pharmacokinetics and metabolism of a new oral antifungal agent, SCH 39304 in rats and cynomolgus monkeys, p. 543.1-543.2. In Recent advances in chemotherapy Proceedings of the 16th International Congress on Chemotherapy E. Lewin-Epstein Ltd.
6. Mojaverian, P., E. Radwanski, M. B. Affrime, M, Cayen, and C. C. Lin. 1994. Pharmacokinetics of the triazole antifungal agent genaconazole in healthy men after oral and intravenous administration. Antimicrob. Agents Chemother. 38:2758-2762.
7. Pfizer Inc. 1990. Diflucan product monograph, p. 53. Pfizer Inc., New York
8. Schering Corporation. 1988. Investigator's brochure: information for the investigational new drug SCH 39304. Schering Corporation, Kenilworth, N.J